Suchergebnisse - "Cordes, Joachim"

PubPharm (36)

1

Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel : a large-scale, open-label, randomised trial (EULAST)

enthalten in: The lancet. Psychiatry | 2023

von Winter-van Rossum, I. | Weiser, M. | Galderisi, S. | +96

ErratumIn: Lancet Psychiatry. 2023 Mar 1;:. - PMID 36870356

2

Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine : Randomized, Double-Blind Trial in Patients With Schizophrenia

enthalten in: Schizophrenia bulletin | 2022

von Heres, S. | Cordes, J. | Feyerabend, S. | +29

3

Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE) : a double-blind randomised controlled trial

enthalten in: The lancet. Psychiatry | 2022

von Schmidt-Kraepelin, C. | Feyerabend, S. | Engelke, C. | +74

CommentIn: Lancet Psychiatry. 2022 Apr;9(4):262-263. - PMID 35276078

4

Hormone replacement therapy with L-thyroxine promotes working memory and concentration in thyroidectomized female patients after differentiated thyroid carcinoma

enthalten in: International journal of psychiatry in medicine | 2020

von Cordes, J. | Woite, M. | Engelke, C. | +6

5

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients : Data From the AMSP Study

enthalten in: The international journal of neuropsychopharmacology | 2019

von Toto, S. | Grohmann, R. | Bleich, S. | +11

6

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine

enthalten in: Schizophrenia research | 2019

von Wagner, E. | Wobrock, T. | Kunze, B. | +20

7

Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial

enthalten in: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 2019

von Veselinović, T. | Scharpenberg, M. | Heinze, M. | +29

8

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia : A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

enthalten in: Schizophrenia bulletin | 2019

von Brown, D. | Nakagome, K. | Cordes, J. | +9

9

Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial

enthalten in: Schizophrenia research | 2019

von Kamp, D. | Engelke, C. | Wobrock, T. | +19

10

EPA guidance on physical activity as a treatment for severe mental illness : a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)

enthalten in: European psychiatry : the journal of the Association of European Psychiatrists | 2018

von Stubbs, B. | Vancampfort, D. | Hallgren, M. | +16